Fingerprint
Dive into the research topics of 'Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
Christof Scheid, Donna Reece, Meral Beksac, Andrew Spencer, Natalie Callander, Pieter Sonneveld, Ghulam Kalimi, Can Cai, Michael Shi, Jeffrey W. Scott, A. Keith Stewart
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations